News Sentiment

NAVA sentiment intelligence

Navamedic ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange OSL Norway
Sector Healthcare Market context
Industry Medical Distribution Read-through group
Latest close 16.40 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.5% over one week, -2.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Navamedic launches Virono®– the first single-dose over-the-counter cold sore tablet

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -3.5% Price reacting lower
Trend fit Trend inactive -2.1% over four weeks
Fair value -40.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Cision News 4

Event Lens

What the news is about

Classified themes
Market update 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4
Cision News Direct company coverage

Navamedic ASA launches Eroxon®

Tone
Neutral 50/100
Event
Market update
Published
12 Feb 2024 08:00
Source
Cision News